MAPP BIOPHARMACEUTICAL, INC.
MAPP BIOPHARMACEUTICAL, INC. has won 13 federal awards worth $192.2M in total across 2 agencies, with a median award of $2.2M. See where they win and what those contracts close for, and forecast the price on a solicitation you're competing for.
13
awards won
$192.2M
total obligated
$2.2M
median award
2
agencies
Recent awards
| Title | Agency | Value | Date |
|---|---|---|---|
| THIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (M | Department Of Health And Human Services | $110.9M | 2022-09-28 |
| PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES | Department Of Health And Human Services | $134.8M | 2022-09-27 |
| BASE YEAR FOR MACV CONTRACT GENERATES MACV IGG2 | Department Of Defense | $768K | 2021-09-24 |
| DEVELOPMENT OF A PAN-BOTULINUM NEUROTOXIN MEDICAL COUNTERMEASURE | Department Of Health And Human Services | $16.3M | 2020-09-28 |
| STTR PHASE II | Department Of Defense | $1.5M | 2020-08-05 |
Agencies they win from
8 more awards + the price forecast for any solicitation this contractor is bidding.
AwardCast forecasts what U.S. federal contracts close for, before you bid. Built on USASpending and SAM.gov. Not affiliated with the U.S. government. Technology by Chosing DEPT.